Comparison of PorA VR types and porA promoter sequence from Neisseria meningitidis B isolated from non-immunised children and vaccine failures immunised with a serogroup B outer membrane protein vaccine

Author： Gorla M.C.O.   Lemos A.P.S.   Sacchi C.T.   de Moraes J.C.   Milagres L.G.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.21, 2003-06, pp. : 2871-2876

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine

By Martin S.L.   Borrow R.   van der Ley P.   Dawson M.   Fox A.J.   Cartwright K.A.V.  

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2476-2481

Elsevier

Access to resources Recommend Favorite

Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine

By van der Ley P.   van der Biezen J.   Poolman J.T.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 401-407

Elsevier

Access to resources Recommend Favorite

Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate

By Fukasawa L.O.   Gorla M.C.O.   Schenkman R.P.F.   Garcia L.R.   Carneiro S.M.   Raw I.   Tanizaki M.M.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2951-2958

Elsevier

Access to resources Recommend Favorite

Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice

By Peeters C.C.A.M.   Claassen I.J.T.M.   Schuller M.   Kersten G.F.A.   Rouppe van der Voort E.M.   Poolman J.T.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2702-2712

Elsevier

Access to resources Recommend Favorite

Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease

By Holst J.   Feiring B.   Fuglesang J.E.   Hoiby E.A.   Nokleby H.   Aaberge I.S.   Rosenqvist E.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 734-737

Elsevier

Access to resources Recommend Favorite